Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias].

Wiener klinische Wochenschrift·2026
Same author

Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).

JAMA oncology·2026
Same author

A cohort study of forced vital capacity, airway obstruction, and survival in the multinational Burden of Obstructive Lung Disease study.

International journal of epidemiology·2026
Same author

Correction: Case Report: Diagnostic challenges in VEXAS syndrome with novel ultrastructural lung findings: IgG4-RD and vasculitis as relevant differential diagnoses.

Frontiers in immunology·2026
Same author

Positive physician perceptions of structured lung ultrasound (LUS) training in interstitial lung disease (ILD): a post-workshop survey study.

Rheumatology international·2026
Same author

Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE).

Annals of medicine·2026

Related Experiment Video

Updated: Jun 10, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease.

Lea Schirnhofer1, Bernd Lamprecht, Natalie Firlei

  • 1Department of Pulmonary Medicine, Paracelsus Medical University Hospital, Salzburg, Austria. l.schirnhofer @ salk.at

Respiration; International Review of Thoracic Diseases
|August 20, 2010
PubMed
Summary

Undiagnosed chronic obstructive pulmonary disease (COPD) is common. Targeted spirometry in individuals with respiratory symptoms and risk factors can halve the rate of undiagnosed irreversible airway obstruction (AO).

More Related Videos

Conducting Respiratory Oscillometry in an Outpatient Setting
14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Related Experiment Videos

Last Updated: Jun 10, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Conducting Respiratory Oscillometry in an Outpatient Setting
14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Area of Science:

  • Pulmonary Medicine
  • Epidemiology

Background:

  • Chronic obstructive pulmonary disease (COPD) prevalence is rising globally, contributing significantly to morbidity and mortality.
  • A substantial number of COPD cases remain undiagnosed, hindering timely intervention and management.

Purpose of the Study:

  • To determine the prevalence of undiagnosed irreversible airway obstruction (AO) in a population sample.
  • To characterize individuals with undiagnosed AO.
  • To assess the impact of targeted spirometry on reducing COPD underdiagnosis.

Main Methods:

  • 1,258 adults aged 40+ completed questionnaires and pre- and post-bronchodilator spirometry.
  • Irreversible AO was defined by post-bronchodilator FEV1/FVC ratio below the lower limit of normal.
  • Targeted spirometry eligibility was based on respiratory symptoms and risk factors (smoking, occupational exposure) without a prior COPD diagnosis.

Main Results:

  • 85.9% of participants with irreversible AO had no prior COPD diagnosis.
  • Undiagnosed AO was less common in severe cases and inversely related to age and prior respiratory conditions.
  • Targeted spirometry identified irreversible AO in 25.1% of eligible individuals, potentially reducing overall underdiagnosis by 50.3%.

Conclusions:

  • Spirometry screening in symptomatic individuals with risk factors can effectively halve the rate of undiagnosed irreversible AO.
  • Identifying and addressing undiagnosed AO is crucial for reducing the global burden of COPD.